CRSP SG&A Expenses

Crispr Therapeutics Ag · SG&A Expenses

CRSP logo

CRSP SG&A Expenses

Latest reported$67.97M
CRSP SG&A Expenses ($5.11M → $67.97M)
High-resolution chart · PNG

CRSP sg&a expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag SG&A Expenses — Annual fiscal periods (USD)
Period endingSG&A Expenses (USD)
73,542,000
72,977,000
76,162,000
102,464,000
99,690,000
85,747,000
63,488,000
48,294,000
35,845,000
31,056,000
13,403,000
5,114,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.